Human Immunoglobulin E (IgE) specific for Pinus ponderosa pollen (Pin p-sIgE)

Polyclonal human IgE antibodies specific for Pinus ponderosa pollen epitopes are the primary mediators of allergic reactions to Ponderosa pine, a common evergreen tree in Western North America. These antibodies are produced by the immune system following sensitization to specific protein components (allergens) within the pine pollen. Once produced, these IgE molecules bind to high-affinity FcεRI receptors on the surface of mast cells and basophils. Upon subsequent exposure to Pinus ponderosa pollen, the allergens cross-link the membrane-bound IgE, triggering the immediate release of histamine, leukotrienes, and cytokines that cause symptoms of allergic rhinitis and asthma. While pine pollen was historically considered a minor allergen due to its large size, it is increasingly recognized as a significant cause of seasonal pollinosis in endemic regions. Therapeutic targeting of these antibodies involves either non-specific sequestration of IgE using monoclonal antibodies like Omalizumab or the induction of immunological tolerance through allergen-specific immunotherapy. Monitoring the levels of these specific IgE antibodies is essential for the diagnosis and management of patients with pine pollen allergies.

Other names

Ponderosa pine-specific IgEAnti-Pinus ponderosa IgEPin p IgEPolyclonal human IgE specific for Ponderosa pine

Anti-IgE monoclonal antibodies like Omalizumab bind to the Cε3 domain of the IgE heavy chain, which is the same site where IgE binds to the high-affinity IgE receptor (FcεRI). By sequestering free IgE in the blood and interstitial fluid, these drugs prevent IgE from attaching to mast cells and basophils, thereby inhibiting the release of inflammatory mediators upon allergen exposure. Allergen-specific immunotherapy (AIT) using Pinus ponderosa extracts works by inducing immune tolerance, shifting the response from a Th2-mediated IgE production toward a Th1/Treg-mediated IgG4 production, which acts as a blocking antibody.